WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006091222) METHODS OF TREATING AND PREVENTING SEVERE ACUTE RESPIRATORY SYNDROME (SARS) WITH AVR118
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/091222    International Application No.:    PCT/US2005/023640
Publication Date: 31.08.2006 International Filing Date: 30.06.2005
IPC:
A61K 48/00 (2006.01)
Applicants: ADVANCED VIRAL RESEARCH CORP. [US/US]; 200 Corporate Blvd. South, Yonkers, NY 10701 (US) (For All Designated States Except US).
HIRSCHMAN, Shalom, Z. [US/US]; (US) (For US Only)
Inventors: HIRSCHMAN, Shalom, Z.; (US)
Agent: ANTLER, Adriane, M.; JONES DAY, 222 East 41st Street, New York, New York 10017-6702 (US)
Priority Data:
60/584,851 01.07.2004 US
Title (EN) METHODS OF TREATING AND PREVENTING SEVERE ACUTE RESPIRATORY SYNDROME (SARS) WITH AVR118
(FR) METHODES DE TRAITEMENT ET DE PREVENTION DU SYNDROME RESPIRATOIRE AIGU SEVERE (SARS) AU MOYEN DE AVR118
Abstract: front page image
(EN)The invention relates to methods for treating Several Acute Respiratory Syndrome (SARS). Specifically, methods for treating patients having SARS comprising administering an effective amount of AVR118, alone or in combination with another medicament, are disclosed. Pharmaceutical compositions and kits comprising AVR118, an additional medicament, and pharmaceutically acceptable carriers are also disclosed.
(FR)L'invention concerne des méthodes de traitement du syndrome respiratoire aigu sévère (SARS). Plus précisément, l'invention concerne des méthodes de traitement de patients soufrant du SARS consistant à administrer une quantité efficace de AVR118, seul ou conjointement avec un autre médicament. L'invention concerne enfin des compositions pharmaceutiques et des kits comprenant AVR118, un médicament supplémentaire et des excipients acceptables sur le plan pharmaceutique.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)